Research links the cocktail party problem with an increased risk of dementia in a study conducted at the University of Oxford. Alzheimer’s Research UK comments on the findings.
Researchers at the UK Dementia Research Institute find that the contents are the gut are important for the creation of new brain cells.
Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
Researchers at the University of Oxford are investigating how iron levels can be used as a marker for dementia.
Researchers at Cardiff University will use stem cell technology to understand how risk genes for Alzheimer’s disease impact how cells in the brain function.
Dr Jonathan Blackman at the University of Bristol is investigating how the Parkinson’s drug, Levodopa may improve sleep and memory in people with mild Alzheimer’s disease.
Research at University College London will investigate how past medical procedures may have transmitted proteins that build up in blood vessels in the brain and cause dementia.
Dr Jonathan Blackman at the University of Bristol has received a £170,000. He will explore whether a chemical called dopamine could help break a cycle associated with sleep problems and Alzheimer’s disease
Over 42,000 people living in Wales have dementia. Now early career dementia researcher, Dr Natalie Connor-Robson at Cardiff University has received a £173,000 funding boost from Alzheimer’s Research UK.
Alzheimer’s Research UK said the dementia crisis cannot be ignored any longer after the Office of National Statistics confirmed that dementia and Alzheimer’s disease was the leading cause of death in England in March 2021.